BNT162b2 (Pfizer/BioNTech) COVID-19 Vaccination Was Not Associated with the Progression of Activity of the Exudative Form of Age-Related Macular Degeneration during Anti-VEGF Therapy.
Bernadetta Płatkowska-AdamskaArkadiusz BociekJoanna KrupińskaMagdalena KalMichał BiskupDorota Zarębska-MichalukDominik OdrobinaPublished in: Vaccines (2022)
In the present study, the activity of the exudative form of AMD did not deteriorate after the administration of the BNT162b2 vaccine.